Late Night Relief IV

Many adults have nights that involve being out later than normal and consuming more alcohol  then they prepared for. This combination can lead to a rough following day that nobody  predicts or has time for – often referred to as a hangover. Scientific studies point hangovers  being caused by dehydration, inflammation and oxidative stress, better known as free radical  response. Alcohol contributes to the reduction of important B vitamins and other nutrients  especially with regular and heavy use. It’s causes dehydration via blocking Anti-Diuretic  Hormone (ADH) which we replenish with at least a liter of fluids each session. If you experience  the symptoms of a hangover such as headaches, upset stomach, vomiting and fatigue, this IV  therapy can help rehydrate, reduce inflammation, relieve headaches and improve energy.

• B-COMPLEX (Vitamins B1, B2, B3, B5, B6, methyl-B12)
1. Zofran – for nausea (or vomiting)
2. Ketorolac – for pain relief (eg, headache)

• Hangovers
• Migraines

Hydrogen Peroxide IV Therapy

Hydrogen Peroxide IV has many benefits in the world of alternative medicine. The theory behind hydrogen peroxide treatment is that it releases extra oxygen inside the body, killing viruses, bacteria, yeast, and fungi. We have seen improved outcomes for our patients when using hydrogen peroxide as an aid to conventional treatments. Due to the limited research on this theory, it is considered alternative treatment and therefore is not a FDA approved method for treating or curing these illnesses.
•Hydrogen Peroxide
•Magnesium Sulfate
•Normal Saline
•Bacterial infections
•Lyme disease
•Viral infections including herpes (shingles) •Epstein-Barr virus
•The common cold
•Sinus infections
•Various fungal infections
•Chronic Bronchitis

•Environmental Allergies/sensitivity

•Chronic Fatigue Syndrome


Glutathione is the body’s most powerful natural antioxidant and is found in every cell in the body. Glutathione is a Tri-peptide (composed of three amino acids, Glutamic Acid, Cysteine, and Glycine) that bolsters the immune system and also helps neutralize damaging free radicals. Free radicals can cause damage to DNA, proteins and cell membranes altering their function, causing mutations and may be implicated in chronic illnesses like cancer or heart disease. Antioxidants can even help your body repair free radical damage caused by such things as stress, radiation, infections, drugs, medications, malnutrition, and aging. Studies have demonstrated that glutathione has the potential to fight almost any disease, particularly those associated with aging.
The Glutathione stores decrease as we age and with exposure to drugs, environmental toxins, Cigarette smoke, and poor diets. When a deficiency in Glutathione develops, oral supplements do not offer an answer because the absorption in the gut is extremely poor. Injection or Intravenous administration is really the gold standard to really maximize the antioxidant effects of Glutathione.
Injection or Intravenous administration is the gold standard to maximize the antioxidant effects of Glutathione. In addition to its work as an antioxidant, glutathione may support the mitochondria, our cell’s main energy producers. This could prevent cell death, meaning that glutathione could have neuroprotective properties that could help with neurodegenerative diseases such as Parkinson’s, MS and Alzheimer.
• GLUTATHIONE (IV push; add Normal Saline for IV drip)
Glutathione can support the treatment of any disease as an anti-oxidant but these have been the following have been found to have the most support:
• General Immunes Support
• Detoxification
• Anti-inflammatory
• Parkinson’s
• Alzheimer’s
• Auto-immune Disorders

• High Blood Pressure

• Skin Lightening

EDTA Chelation

Jeffrey A. Weiss, MD:

I completed my Fellowship in Advanced Heart Failure and Heart Transplant Medicine at Newark Beth Israel Hospital, so this month’s “Heart Health Awareness Month”, is a topic that is near and dear to my heart. Currently, 1 in 4 Americans die of heart disease, with coronary artery disease (CAD) being the leading cause of death among American men and women alike.

Since heart disease is such a major killer, I want to share important new information about cardiac chelation (key-LAY-shun) therapy. You may have heard that it is alternative medicine, voodoo, expensive, and even dangerous. However, recent research funded by the National Institutes of Health suggests that this old treatment  can benefit patients with diabetes mellitus and prior heart attacks.

Chelation therapy was first used in the early 20th century to treat heavy metal poisoning. The treatment involves administering a drug called a chelator, which has a magnetically charged pocket that can “grab” a metal and hang onto it, like a strong magnet, allowing the metal to be excreted out the urine. One chelator, calcium ethylenediaminetetraacetic acid (EDTA), is approved by the US Food and Drug Administration to treat lead poisoning. There are reasons to think that chelation to remove metals might treat or prevent heart disease. Many complications of diabetes mellitus are likely caused by chemical reactions that happen to the excess sugar in the blood. These reactions are catalyzed, or facilitated, by metals. Our environment is polluted with metals that are toxic to our systems, especially in the tristate area. Lead (toys, soil, gasoline, plumbing), arsenic (well water), mercury (many fish), and cadmium (from rechargeable batteries) are among the top 10 most toxic substances listed by the US government. EDTA chelates lead and cadmium.

Chelation treatment was first reported to have clinical benefits in patients with symptomatic coronary artery disease through a fortuitous set of observations starting in 1956. Subsequent clinical investigations of chelation, however, were mixed and serious research in this area ceased in the early 1960’s. Alternative medicine practitioners continued to use chelation for prevention of complications of atherosclerosis based on their anecdotal experiences. Because of the lack of proof of benefit and the implausibility of the proposed mechanism of benefit (physical removal of calcium from complex atherosclerotic plaques), most major mainstream medical organizations during the 1980’s and 1990’s made policy statements against chelation.

When teaching medical students, residents and fellows, I like to pretend that I’m talking to patients to get them to lessen their grip on medical jargon in preparation for patient interactions. When talking about the heart and cardiovascular system, I make an analogy of it being a home with plumbing and electric systems. For example, when the plumbing (circulation) is compromised, it adversely affects the electric (rhythm). When you think of arteries as pipes that get clogged, you see it’s a mechanical problem and that medication can only go so far at alleviating it. Short of a root-rooter (left heart catheterization with angioplasty and stent), the most effective way of cleaning the pipes would be Drain-O (chelation), something you can infuse into the circulatory system that hits plaque and allows you to eliminate it via urination.

The first Trial to Assess Chelation Therapy (TACT1) was developed because members of the U.S. Congress expressed concern that chelation use was widespread yet there was no reliable data on either its safety or efficacy. TACT1 was completed in 2012 (enrolling 1708 patients) and it showed that a combination of up to 40 infusions total with intravenous (IV) di-sodium EDTA plus oral multivitamins and multi-minerals (OMVM) compared with intravenous and oral placebo, led to a significant reduction in cardiovascular event in patients with prior myocardial infarction, age 50 or older, already treated with standard evidence-based medical therapies (aspirin, statin, beta-blocker, and ACE inhibitor or angiotensin receptor blocker). In the subgroup with diabetes (633 patients), the results were dramatic: the chelation-based strategy reduced cardiac events by 51% and reduced total mortality by 43%. There is nothing else available today that is comparable in diabetes therapies – Aspirin comes closest at 28% reduction in mortality (after 2 years of use, with a number needed to treat (NNT) of 330* compared to only 6 months to benefit and a NNT of 6). In response to the data from TACT1, the American College of Cardiology/American Heart Association allowed chelation for treatment of chronic ischemic heart disease.

The landscape for chelation therapy has changed, and environmental toxins have emerged as modifiable risk factors for heart disease (Environmental Cardiology). The US Food and Drug Administration reviewed the TACT in a positive light but encouraged researchers to carry out another study to confirm these results (TACT2). TACT1 examined the two major components of the chelation strategy in common use by alternative medicine practitioners, EDTA chelation and oral multivitamins and multi-minerals (OMVM). Because the analyses found those two therapies provided additive benefits, both the NIH and FDA supported the decision to test the strongest strategy in TACT2, chelation plus OMVM, to promote the most efficient trial possible. TACT2 will enroll 1200 patients with diabetes who are 50 years of age or older, have had a heart attack (prior myocardial infarction [MI]), and have good kidney function (serum creatinine 2.0 mg/dL or less). Patients will be randomly allocated to receive either chelation plus OMVM, or placebo (inactive substance). All patients will be followed for approximately five years. Because this study focuses on those who benefited the most in the TACT1 trial, researchers anticipate even more impressive results.

To learn more about the benefits of chelation therapy and to schedule a Consultation with Jeffrey A. Weiss, MD, FACP, please call the Infusion Center of New Jersey at 973-272-6220 or book via our website at at 842 Clifton Avenue, Suite 4, Clifton, NJ 07013.

acam logo
american board aesthetic medicine
ACP logo12X9

Get in Touch


*All indicated fields must be completed. Please include non-medical
questions and correspondence only.”


SCR 20221017 bqp

Accessibility Toolbar